Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Cadila Healthcare Limited
  6. Summary
    CADILAHC   INE010B01027

CADILA HEALTHCARE LIMITED

(CADILAHC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
605.55(c) 598.75(c) 577.35(c) 572(c) 586.1(c) Last
3 376 653 6 212 666 4 685 224 2 448 180 3 187 410 Volume
-1.58% -1.12% -3.57% -0.93% +2.47% Change
More quotes
Estimated financial data (e)
Sales 2022 163 B 2 188 M 2 188 M
Net income 2022 26 184 M 352 M 352 M
Net Debt 2022 21 544 M 290 M 290 M
P/E ratio 2022 26,7x
Yield 2022 0,73%
Sales 2023 175 B 2 355 M 2 355 M
Net income 2023 24 810 M 334 M 334 M
Net Debt 2023 13 409 M 180 M 180 M
P/E ratio 2023 24,3x
Yield 2023 0,76%
Capitalization 600 B 8 070 M 8 071 M
EV / Sales 2022 3,82x
EV / Sales 2023 3,50x
Nbr of Employees 15 856
Free-Float 25,0%
More Financials
Company
Cadila Healthcare Limited is an India-based pharmaceutical company. The Company's subsidiaries include Zydus Wellness Limited, Windlas Healthcare Pvt Ltd, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited, German Remedies Limited, Dialforhealth India Limited, Dialforhealth Unity Limited and Dialforhealth Greencross Limited, among others. 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
More about the company
Ratings of Cadila Healthcare Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CADILA HEALTHCARE LIMITED
07/30CADILA HEALTHCARE : Gets US FDA Nod for Breast Cancer Treatment Drug
MT
07/28CADILA HEALTHCARE LIMITED : Ex-dividend day for final dividend
FA
07/21CADILA HEALTHCARE : Gets Preliminary US FDA Nod for Cancer Treatment Drug
MT
07/21CADILA HEALTHCARE : Zydus Cadila receives tentative approval from the USFDA for ..
PU
07/21CADILA HEALTHCARE : European Medicines Agency grants Orphan Drug Designation to ..
PU
07/21CADILA HEALTHCARE : Gets US FDA's Tentative Approval for Blood Cancer Drug Ibrut..
MT
07/21Zydus Cadila Receives Tentative Approval from the USFDA for Ibrutinib Tablets
CI
07/21CADILA HEALTHCARE : Saroglitazar Gets Orphan Drug Status in Europe
MT
07/19CADILA HEALTHCARE : Zydus Animal Health and Investments Limited
PU
07/17CADILA HEALTHCARE : Annual Report (2020-2021)
PU
07/17CADILA HEALTHCARE : Dialforhealthe Unilty Limited
PU
07/16CADILA HEALTHCARE : Zydus VTEC Limited
PU
07/15CADILA HEALTHCARE : Completes Sale of Animal Healthcare Subsidiary Arm
MT
07/09Cadila Healthcare Limited Announces Resignation of Ganesh N. Nayak as Whole T..
CI
07/08CADILA HEALTHCARE : Zydus Pharmaceuticaals Limited
PU
More news
News in other languages on CADILA HEALTHCARE LIMITED
02/23Farmacéuticas indias se vuelven locales para terminar con dependencia de Chin..
2018Des laboratoires indiens intéressés par les génériques de Sanofi
More news
Chart CADILA HEALTHCARE LIMITED
Duration : Period :
Cadila Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CADILA HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 28
Last Close Price 586,10 INR
Average target price 603,63 INR
Spread / Average Target 2,99%
EPS Revisions
Managers and Directors
Sharvil Pankajbhai Patel Managing Director & Executive Director
Nitin Dalsukhrai Parekh Chief Financial Officer
Pankaj Ramanbhai Patel Non-Executive Chairman
Ganesh Narayan Nayak Chief Operating Officer & Executive Director
Dhaval N. Soni Secretary & Compliance Officer